Literature DB >> 30293950

The promising role of miR-296 in human cancer.

Lingling Zhu1, Hanyu Deng1, Jia Hu1, Shanshan Huang2, Jianping Xiong3, Jun Deng4.   

Abstract

MicroRNAs (MiRNAs) are small non-protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial-mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cancer; MiR-296; Target genes

Mesh:

Substances:

Year:  2018        PMID: 30293950     DOI: 10.1016/j.prp.2018.09.026

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  11 in total

1.  Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.

Authors:  Shuwei Zhang; Chen Li; Junchao Liu; Fengxue Geng; Xiaoting Shi; Qian Li; Ze Lu; Yaping Pan
Journal:  FEBS J       Date:  2020-02-12       Impact factor: 5.542

2.  miR‑27a‑3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells.

Authors:  Hongxin Chen; Binlin Cai; Kun Liu; Qingquan Hua
Journal:  Mol Med Rep       Date:  2021-02-04       Impact factor: 2.952

3.  Low miR-1273a expression predicts poor prognosis of colon cancer and facilitates tumor cell proliferation, migration, and invasion.

Authors:  Lei Sun; Xin Zhou; Qian Jiang; Yiping Zhuang; Dongzheng Li
Journal:  Braz J Med Biol Res       Date:  2021-01-08       Impact factor: 2.590

4.  The biomarkers of key miRNAs and gene targets associated with extranodal NK/T-cell lymphoma.

Authors:  Yin-Yin Peng; Hong-Bin Zhang; Xin Wang; Qing Xiao; Shu-Liang Guo
Journal:  Open Med (Wars)       Date:  2022-01-04

5.  Serum MicroRNA-137 Serves as a Novel Biomarker for Cerebral Atherosclerosis Diagnosis and Cerebrovascular Event Prediction.

Authors:  Jingjing Xuan; Meiling Shang; Xuelian Li
Journal:  J Cardiovasc Pharmacol       Date:  2021-06-01       Impact factor: 3.271

6.  Integrative analysis of TCGA data identifies miRNAs as drug-specific survival biomarkers.

Authors:  Shuting Lin; Jie Zhou; Yiqiong Xiao; Bridget Neary; Yong Teng; Peng Qiu
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996

7.  Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma.

Authors:  He Wang; Huiwen Wang; Wenyu Cui; Qiao Zhang; Jing Li; Qi Zhang
Journal:  Diagn Pathol       Date:  2021-06-11       Impact factor: 2.644

8.  CircRNA WHSC1 targets the miR-646/NPM1 pathway to promote the development of endometrial cancer.

Authors:  Yao Liu; Shuo Chen; Zhi-Hong Zong; Xue Guan; Yang Zhao
Journal:  J Cell Mol Med       Date:  2020-05-07       Impact factor: 5.310

Review 9.  Preventive and Therapeutic Roles of Berberine in Gastrointestinal Cancers.

Authors:  Siwang Hu; Ruochi Zhao; Yahui Liu; Junzheng Chen; Zhijian Zheng; Shuangshuang Wang
Journal:  Biomed Res Int       Date:  2019-12-28       Impact factor: 3.411

10.  CircASXL1 knockdown represses the progression of colorectal cancer by downregulating GRIK3 expression by sponging miR-1205.

Authors:  Guojiu Fang; Yibin Wu; Xueli Zhang
Journal:  World J Surg Oncol       Date:  2021-06-14       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.